These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21471053)

  • 1. Stenotrophomonas maltophilia in cystic fibrosis: guilty or innocent?
    Colin AA; Rabin HR
    Am J Respir Crit Care Med; 2011 Mar; 183(5):564-6. PubMed ID: 21471053
    [No Abstract]   [Full Text] [Related]  

  • 2. Stenotrophomonas maltophilia: to be or not to be a cystic fibrosis pathogen.
    Hansen CR
    Curr Opin Pulm Med; 2012 Nov; 18(6):628-31. PubMed ID: 22990659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Water filters can prevent Stenotrophomonas maltophilia contamination of nebuliser equipment used by people with cystic fibrosis.
    Woodhouse R; Peckham DG; Conway SP; Denton M
    J Hosp Infect; 2008 Apr; 68(4):371-2. PubMed ID: 18353498
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis.
    Dalbøge CS; Hansen CR; Pressler T; Høiby N; Johansen HK
    J Cyst Fibros; 2011 Sep; 10(5):318-25. PubMed ID: 21463972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic information on Stenotrophomonas maltophilia ST264 isolated from a cystic fibrosis pediatric patient in Brazil.
    Braga FS; D'Allincourt Carvalho Assef AP; Leão RS; Albano RM; Marques EA
    Braz J Microbiol; 2020 Sep; 51(3):1125-1127. PubMed ID: 31858443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stenotrophomonas maltophilia bacteraemia in two patients with cystic fibrosis associated with totally implantable venous access devices.
    Ratnalingham RA; Peckham D; Denton M; Kerr K; Conway S
    J Infect; 2002 Jan; 44(1):53-5. PubMed ID: 11972423
    [No Abstract]   [Full Text] [Related]  

  • 7.
    Willsey GG; Eckstrom K; LaBauve AE; Hinkel LA; Schutz K; Meagher RJ; LiPuma JJ; Wargo MJ
    J Bacteriol; 2019 Aug; 201(15):. PubMed ID: 31109991
    [No Abstract]   [Full Text] [Related]  

  • 8. Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease.
    Waters V; Yau Y; Prasad S; Lu A; Atenafu E; Crandall I; Tom S; Tullis E; Ratjen F
    Am J Respir Crit Care Med; 2011 Mar; 183(5):635-40. PubMed ID: 20889901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of respiratory isolates of Stenotrophomonas maltophilia by commercial biochemical systems and species-specific PCR.
    Giordano A; Magni A; Trancassini M; Varesi P; Turner R; Mancini C
    J Microbiol Methods; 2006 Jan; 64(1):135-8. PubMed ID: 15927289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients.
    Nazik H; Ongen B; Erturan Z; Salcioğlu M
    Jpn J Infect Dis; 2007 May; 60(2-3):82-6. PubMed ID: 17515637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis.
    Waters V; Atenafu EG; Salazar JG; Lu A; Yau Y; Matukas L; Tullis E; Ratjen F
    J Cyst Fibros; 2012 Jan; 11(1):8-13. PubMed ID: 21849265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology of Stenotrophomonas maltophilia isolated from cystic fibrosis patients.
    Denton M; Kerr KG
    J Clin Microbiol; 2002 May; 40(5):1884. PubMed ID: 11980986
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between glucose intolerance and bacterial colonisation in an adult population with cystic fibrosis, emergence of Stenotrophomonas maltophilia.
    Lehoux Dubois C; Boudreau V; Tremblay F; Lavoie A; Berthiaume Y; Rabasa-Lhoret R; Coriati A
    J Cyst Fibros; 2017 May; 16(3):418-424. PubMed ID: 28284526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stenotrophomonas maltophilia strains from cystic fibrosis patients: genomic variability and molecular characterization of some virulence determinants.
    Nicoletti M; Iacobino A; Prosseda G; Fiscarelli E; Zarrilli R; De Carolis E; Petrucca A; Nencioni L; Colonna B; Casalino M
    Int J Med Microbiol; 2011 Jan; 301(1):34-43. PubMed ID: 20952251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-control study of Stenotrophomonas maltophilia acquisition in cystic fibrosis patients.
    Marchac V; Equi A; Le Bihan-Benjamin C; Hodson M; Bush A
    Eur Respir J; 2004 Jan; 23(1):98-102. PubMed ID: 14738239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Manipulation of Stenotrophomonas maltophilia.
    Welker E; Domfeh Y; Tyagi D; Sinha S; Fisher N
    Curr Protoc Microbiol; 2015 May; 37():6F.2.1-14. PubMed ID: 26344220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging and unusual gram-negative infections in cystic fibrosis.
    Davies JC; Rubin BK
    Semin Respir Crit Care Med; 2007 Jun; 28(3):312-21. PubMed ID: 17562501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of an older patient with Stenotrophomonas maltophilia: is it an emerging pathogen in cystic fibrosis?
    Dobbin CJ; Bye PT
    Intern Med J; 2001 Nov; 31(8):499-500. PubMed ID: 11720067
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased arterial stiffness in children with cystic fibrosis.
    Buehler T; Steinmann M; Singer F; Regamey N; Casaulta C; Schoeni MH; Simonetti GD
    Eur Respir J; 2012 Jun; 39(6):1536-7. PubMed ID: 22654008
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification and management of unusual pathogens in cystic fibrosis.
    Elborn JS
    J R Soc Med; 2008 Jul; 101 Suppl 1(Suppl 1):S2-5. PubMed ID: 18607011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.